PRESS RELEASE published on 03/10/2026 at 07:30, 2 months 2 days ago Evotec Announces ‘Horizon’ – Next Inflection in Its Strategic Transformation to Accelerate Growth and Promote Agility Evotec SE announces 'Horizon', the next phase in its strategic transformation to accelerate growth and promote agility through a new operating model across operations, science, and commercial execution Evotec SE Growth Strategic Transformation Horizon Operating Model
BRIEF published on 01/08/2026 at 07:35, 4 months 4 days ago Evotec Biologics obtient une subvention pour l'IA dans le développement d'anticorps monoclonaux Evotec SE Anticorps Monoclonaux Fondation Gates Optimisation Par IA Plateforme J.DESIGN™
BRIEF published on 01/08/2026 at 07:35, 4 months 4 days ago Just – Evotec Biologics Secures Grant for AI in Monoclonal Antibody Development Evotec SE AI Optimization Monoclonal Antibodies Gates Foundation J.DESIGN™ Platform
PRESS RELEASE published on 01/08/2026 at 07:30, 4 months 4 days ago Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access Just - Evotec Biologics, a subsidiary of Evotec SE, receives grant from Gates Foundation to optimize monoclonal antibody development using AI-driven molecular design, enhancing affordability and global access Evotec SE Grant Just - Evotec Biologics Gates Foundation Monoclonal Antibody
BRIEF published on 01/01/2026 at 07:35, 4 months 11 days ago Evotec Appoints Dr. Sarah Fakih as EVP of Global Communications and Investor Relations Investor Relations Leadership Communications Evotec Sarah Fakih
BRIEF published on 01/01/2026 at 07:35, 4 months 11 days ago Evotec nomme Sarah Fakih au poste de vice-présidente exécutive des communications mondiales et des relations avec les investisseurs. Direction Communications Relations Avec Les Investisseurs Evotec Sarah Fakih
PRESS RELEASE published on 01/01/2026 at 07:30, 4 months 11 days ago Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment Investor Relations Appointment Evotec Global Communications Dr. Sarah Fakih
BRIEF published on 12/08/2025 at 07:05, 5 months 4 days ago Evotec Finalizes Sale of Toulouse Site to Sandoz for $350 Million Revenue Growth Biosimilars Evotec Sandoz Technology License
BRIEF published on 12/08/2025 at 07:05, 5 months 4 days ago Evotec finalise la vente de son site de Toulouse à Sandoz pour 350 millions de dollars. Croissance Des Revenus Licence Technologique Evotec Biosimilaires Sandoz
PRESS RELEASE published on 12/08/2025 at 07:00, 5 months 4 days ago Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz Evotec closes sale of Just - Evotec Biologics' Toulouse site to Sandoz for over US$650m, including technology license fees. Sale improves revenue mix and profit margins Technology Sale Evotec Sandoz Biologics
Published on 05/13/2026 at 00:00, 15 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 21:55, 2 hours 20 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 2 hours 33 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 9 hours 45 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 23:47, 27 minutes ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 1 hour 49 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 3 hours 53 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 4 hours 39 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 4 hours 40 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 6 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 6 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 6 hours 5 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 6 hours 5 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 6 hours 25 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités